28 results on '"Bremer-Hoffmann, Susanne"'
Search Results
2. Review of New Approach Methodologies for Application in Risk Assessment of Nanoparticles in the Food and Feed Sector: Status and Challenges.
3. Proposal for a qualification system for New Approach Methodologies (NAMs) in the food and feed sector: example of implementation for nanomaterial risk assessment.
4. Tiered testing of micro- and nanoplastics using intestinal in vitro models to support hazard assessments
5. Fostering scientific integrity and research ethics in a science-for-policy research organisation
6. EFSA Project on the use of New Approach Methodologies (NAMs) for the hazard assessment of nanofibres. Lot 1, nanocellulose oral exposure: gastrointestinal digestion, nanofibres uptake and local effects
7. Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells
8. Inter-Individual Variations: A Challenge for the Standardisation of Complement Activation Assays
9. Use of New Approach Methodologies for the hazard assessment of nanocellulose oral exposure: the EFSA granted NANOCELLUP project
10. Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles
11. Toxic effects of nanomaterials for health applications: How automation can support a systematic review of the literature?
12. Development of a pluripotent stem cell derived neuronal model to identify chemically induced pathway perturbations in relation to neurotoxicity: Effects of CREB pathway inhibition
13. Bridging communities in the field of nanomedicine
14. Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products
15. Nanomedicines - Tiny particles and big challenges
16. Toxic effects of nanomaterials for health applications: How automation can support a systematic review of the literature?
17. Main trends of immune effects triggered by nanomedicines in preclinical studies
18. Mapping of the available standards against the regulatory needs for nanomedicines
19. Identification of regulatory needs for nanomedicines
20. Are existing standard methods suitable for the evaluation of nanomedicines: some case studies
21. Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles
22. Nanomedicines in the European translational process
23. Changes in miRNA Expression Profiling during Neuronal Differentiation and Methyl Mercury-Induced Toxicity in Human in Vitro Models
24. Standardization of pluripotent stem cell cultures for toxicity testing
25. Mapping of the available standards against the regulatory needs for nanomedicines.
26. Development of a pluripotent stem cell derived neuronal model to identify chemically induced pathway perturbations in relation to neurotoxicity: Effects of CREB pathway inhibition
27. Mapping of the available standards against the regulatory needs for nanomedicines.
28. Current status of human pluripotent stem cell based in vitro toxicity tests.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.